The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARS PHARMACEUTICALS INC | COM | 82835W108 | 12,434,289 | 1,910,029 | SH | SOLE | 1,910,029 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 7,847,697 | 287,251 | SH | SOLE | 287,251 | 0 | 0 | |||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 1,180,191 | 375,857 | SH | SOLE | 375,857 | 0 | 0 | |||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 12,492,313 | 1,221,145 | SH | SOLE | 1,221,145 | 0 | 0 | |||
| EQRX INC | COM | 26886C107 | 25,422,583 | 13,104,424 | SH | SOLE | 13,104,424 | 0 | 0 | |||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 14,559,250 | 2,329,480 | SH | SOLE | 2,329,480 | 0 | 0 | |||
| KRONOS BIO INC | COM | 50107A104 | 2,119,244 | 1,451,537 | SH | SOLE | 1,451,537 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,486,525 | 521,284 | SH | SOLE | 521,284 | 0 | 0 | |||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 10,301,738 | 625,485 | SH | SOLE | 625,485 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 104,824,198 | 4,839,529 | SH | SOLE | 4,839,529 | 0 | 0 | |||
| THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 5,428,433 | 611,310 | SH | SOLE | 611,310 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 40,473,613 | 2,518,582 | SH | SOLE | 2,518,582 | 0 | 0 | |||